The Flowr Corporation

TSXV:FLWR.H Stock Report

Market Cap: CA$10.7m

Flowr Past Earnings Performance

Past criteria checks 0/6

Flowr's earnings have been declining at an average annual rate of -49.7%, while the Pharmaceuticals industry saw earnings growing at 27.3% annually. Revenues have been growing at an average rate of 44.1% per year.

Key information

-49.7%

Earnings growth rate

-20.8%

EPS growth rate

Pharmaceuticals Industry Growth23.1%
Revenue growth rate44.1%
Return on equity-740.2%
Net Margin-762.8%
Last Earnings Update30 Sep 2022

Recent past performance updates

Recent updates

Flowr's (CVE:FLWR) Stock Price Has Reduced 79% In The Past Year

Jan 18
Flowr's (CVE:FLWR) Stock Price Has Reduced 79% In The Past Year

The Flowr Corporation (CVE:FLWR) Analysts Are More Bearish Than They Used To Be

Nov 26
The Flowr Corporation (CVE:FLWR) Analysts Are More Bearish Than They Used To Be

How Many The Flowr Corporation (CVE:FLWR) Shares Did Insiders Buy, In The Last Year?

Jul 21
How Many The Flowr Corporation (CVE:FLWR) Shares Did Insiders Buy, In The Last Year?

Revenue & Expenses Breakdown

How Flowr makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSXV:FLWR.H Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2212-95131
30 Jun 2213-99151
31 Mar 2212-84141
31 Dec 2112-86162
30 Sep 2110-118152
30 Jun 2110-120161
31 Mar 2110-122191
31 Dec 208-126221
30 Sep 206-47261
30 Jun 204-53311
31 Mar 204-36351
31 Dec 195-31331
30 Sep 198-14310
30 Jun 197-4260
31 Mar 194-19200
31 Dec 183-15150
30 Sep 180-11100
30 Jun 180-670
31 Mar 180-440
31 Dec 170-230

Quality Earnings: FLWR.H is currently unprofitable.

Growing Profit Margin: FLWR.H is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: FLWR.H is unprofitable, and losses have increased over the past 5 years at a rate of 49.7% per year.

Accelerating Growth: Unable to compare FLWR.H's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: FLWR.H is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (109.7%).


Return on Equity

High ROE: FLWR.H has a negative Return on Equity (-740.24%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.